Elizabeth A. Belloli

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Hypersensitivity Pneumonitis

Margaret L. Salisbury, Tian Gu, Susan Murray et al. · CHEST Journal · 2018 · 213 citations · Full text

Medicine, Immunology, Radiology +11

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

Joshua J. Solomon, Sonye K. Danoff, Felix Woodhead et al. · The Lancet Respiratory Medicine · 2022 · 208 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

Toby M. Maher, Paul Ford, Kevin M. Brown et al. · JAMA · 2023 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis

Margaret L. Salisbury, Barry H. Gross, Aamer Chughtai et al. · European Respiratory Journal · 2018 · 82 citations · Full text

Medicine, Internal Medicine, Radiology +17